12 followers
UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY’s current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases.
Anirvan Ghosh
Gameto
4 followers
Synthekine
3 followers
Tango Therapeutics
2 followers
Caribou Biosciences
2 followers
Vera Therapeutics
2 followers
Neogene Therapeutics
2 followers
Kyverna Therapeutics
7 followers
Day One Biopharmaceuticals
1 follower
Apogee Therapeutics
1 follower
Cargo
1 follower
Aura Biosciences
1 follower
Explore companies